Open Access

The urgency to treat LDL-c post MI: The role of PCSK9 mAbs in reaching goals.

Congress Session

About the speaker

Professor Derek Leslie Connolly

City Hospital, Birmingham (United Kingdom of Great Britain & Northern Ireland)
12 presentations
0 follower

3 more presentations in this session

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

Speaker: Professor K. Ray (London, GB)

Thumbnail

Expanding therapeutic options for lowering LDL-c: Where will bempedoic acid and inclisiran contribute.

Speaker: Doctor C. Ballantyne (Houston, US)

Thumbnail

Panel Discussion: The case for combination therapy: The way forward in intensive LDL-c management?

Speaker: Professor J. Kastelein (Amsterdam, NL)

Thumbnail

Access the full session

Redefining intensive LDL-c management in high risk patients: The case for combination therapy

Speakers: Professor D. Connolly, Professor K. Ray, Doctor C. Ballantyne, Professor J. Kastelein
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Severe spasm at the proximal LAD segment during the epicardial PVC ablation.

27 August 2021

ESC Premium Access

Sudden Cardic Death in a 41 year old man with mitral valve prolapse.

27 August 2021

ESC Premium Access

STROKESTOP: Cost-effectiveness of population screening for atrial fibrillation based on long-term follow-up data

27 August 2021

This platform is supported by

logo Novo Nordisk